Stephens Inc. AR Sells 431 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Stephens Inc. AR lowered its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 6.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,045 shares of the company’s stock after selling 431 shares during the quarter. Stephens Inc. AR’s holdings in HealthEquity were worth $580,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Wasatch Advisors LP grew its stake in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the period. Vaughan Nelson Investment Management L.P. grew its stake in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Barclays PLC grew its stake in shares of HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after purchasing an additional 112,667 shares during the period. Thrivent Financial for Lutherans grew its stake in shares of HealthEquity by 33.3% during the third quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock worth $24,033,000 after purchasing an additional 73,404 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of HealthEquity during the third quarter worth $5,675,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $112.69 on Friday. The firm has a market cap of $9.77 billion, a price-to-earnings ratio of 103.39, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The stock’s 50-day moving average is $102.14 and its 200-day moving average is $90.76. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the business posted $0.40 EPS. Equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of analyst reports. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, Royal Bank of Canada boosted their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,000 shares of company stock worth $3,895,788. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.